KALV vs XOM · rev $13.7M vs P/E 24, rev $201.16B
Kalvista Pharmaceuticals Inc (KALV) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren W. Woods.
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
KALV currently screens at market cap $1.44B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the KALV and XOM stock pages for the full models.
Not investment advice.